Michael Christopher Laufersweiler

Title: Michael Christopher Laufersweiler: Innovator in Sulfonamide Derivatives

Introduction

Michael Christopher Laufersweiler is a notable inventor based in Maineville, OH (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of sulfonamide derivatives. With a total of 6 patents to his name, Laufersweiler has demonstrated a commitment to innovation and research.

Latest Patents

Laufersweiler's latest patents focus on sulfonamide derivatives. These inventions relate to compounds of specific formulas and their pharmaceutically acceptable salts, solvates, or tautomers. The patents detail processes for the preparation of these compounds, intermediates used in their preparation, and compositions containing such compounds. Notably, these compounds are aimed at treating pain, showcasing Laufersweiler's dedication to addressing significant medical needs.

Career Highlights

Throughout his career, Laufersweiler has worked with prominent companies in the pharmaceutical industry, including Pfizer Corporation and Icagen, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in drug development.

Collaborations

Laufersweiler has collaborated with several professionals in his field, including Serge Beaudoin and Christopher John Markworth. These partnerships have likely enhanced his research and innovation efforts, leading to the successful development of his patented compounds.

Conclusion

Michael Christopher Laufersweiler is a distinguished inventor whose work in sulfonamide derivatives has the potential to impact pain management significantly. His contributions to the pharmaceutical industry reflect his dedication to innovation and improving healthcare outcomes.